Novartis investors are stepping up scrutiny of the company's dealmaking after setbacks to drugs it acquired through mergers ...

Platinum chemotherapy's long-term effects, surprising heart failure drug failures, and more biotech news from The Readout ...

About four dozen children who attended a community party in August 2025 later developed skin and soft tissue lesions and ...

The Trump administration is promising to send $500 refund checks to nearly 1 million people with Affordable Care Act health ...

Platinum chemotherapy aged the liver cells of treated children, making them look more like adult liver cells and possibly ...

The pharma industry invested billions of dollars to develop drugs heralded as the next era in the treatment of heart disease ...

Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen on ...

There has been rancorous debate over doctors accepting free gifts and speaking fees from pharma companies. That doesn't mean ...

A major Novartis shareholder has called for a shake-up of the drugmaker's board after its shares suffered a record fall ...

UniQure readout tests durability of benefits, an AI effort to manage heart failure, and more biotech news from The Readout ...

Nothing in the recent reporting about John Fetterman is medically surprising,” write Michael P.H. Stanley and Isaiah Kletenik.

The two measles-related deaths in Pennsylvania last month involved infants, and the virus itself caused one of the deaths, a ...